Literature DB >> 16771243

Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients.

H Zeki Tonbul1, Murat Demir, Lütfullah Altintepe, Ibrahim Güney, Ekrem Yeter, Süleyman Türk, Mehdi Yeksan, Alaattin Yildiz.   

Abstract

BACKGROUND: Malnutrition, inflammation, and atherosclerosis (MIA syndrome) are common in end-stage renal disease (ESRD) patients. Each component of MIA syndrome is the predictor of outcomes in ESRD patients. In this cross-sectional study, we aimed to compare both dialysis modalities for MIA syndrome components.
MATERIAL AND METHODS: Thirty hemodialysis (HD) (mean age 44 +/- 11 years, 14 male and 16 female, mean time on dialysis: 31.0 +/- 19.0 months) and 30 continuous ambulatory peritoneal dialysis (CAPD) patients (41 +/- 9 years, 12 male and 18 female, mean time on dialysis: 25.5 +/- 21.5 months) were included. In order to determine malnutrition in ESRD patients, serum albumin level and anthropometric measurements were used. For inflammation, serum C-reactive protein level, erythrocyte sedimentation rate, and fibrinogen levels were measured. Mean-carotid artery intima media thickness (m-CIMT), presence of carotid plaque and serum homocysteine level were used to determine atherosclerosis.
RESULTS: Five CAPD patients (16%) and one HD patient (3%) was hypoalbuminemic. HD and CAPD groups were similar for inflammation. Mean-CIMT and serum homocysteine level were higher in HD patients than CAPD patients. There was a positive correlation between homocysteine and m-CIMT.
CONCLUSION: Before choosing renal replacement therapy, malnutrition, inflammation, and atherosclerosis parameters must be investigated in ESRD patients. Hemodialysis seems to be more advantageous for malnutrition components than CAPD. Both dialysis modalities seem to be similar for inflammation, and CAPD modality has superiority for atherosclerosis. Before choosing the type of renal replacement therapy, assessment of MIA syndrome components could be useful for individualization of the decision on which dialytic modality is appropriate in ESRD patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771243     DOI: 10.1080/08860220600583625

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  16 in total

1.  The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients.

Authors:  Kultigin Turkmen; Hatice Kayikcioglu; Orhan Ozbek; Yalcin Solak; Mehmet Kayrak; Cigdem Samur; Melih Anil; Halil Zeki Tonbul
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

2.  CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.

Authors:  Julio A Lamprea-Montealegre; Brad C Astor; Robin L McClelland; Ian H de Boer; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; A Richey Sharrett; Moyses Szklo
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

3.  Cardiac MRI measurements of pericardial adipose tissue volumes in patients on in-centre nocturnal hemodialysis.

Authors:  Sean Cai; Ron Wald; Djeven P Deva; Mercedeh Kiaii; Ming-Yen Ng; Gauri R Karur; Oblugbenga Bello; Zhuo Jun Li; Jonathon Leipsic; Laura Jimenez-Juan; Anish Kirpalani; Kim A Connelly; Andrew T Yan
Journal:  J Nephrol       Date:  2019-11-14       Impact factor: 3.902

4.  Progression of coronary calcification in pediatric chronic kidney disease stage 5.

Authors:  Mahmut Civilibal; Salim Caliskan; Sebuh Kurugoglu; Cengiz Candan; Nur Canpolat; Lale Sever; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-11-04       Impact factor: 3.714

5.  Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients.

Authors:  K Turkmen; H Z Tonbul; F M Erdur; I Guney; H Kayikcioglu; L Altintepe; O Ozbek; M I Yilmaz; A Gaipov; S Turk; A Covic; M Kanbay
Journal:  Int Urol Nephrol       Date:  2012-09-23       Impact factor: 2.370

6.  Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients.

Authors:  Marta Opalinska; Tomasz Stompor; Dorota Pach; Renata Mikolajczak; Danuta Fedak; Marcin Krzanowski; Tomasz Rakowski; Anna Sowa-Staszczak; Boguslaw Glowa; Piotr Garnuszek; Michał Maurin; Urszula Karczmarczyk; Władysław Sulowicz; Alicja Hubalewska-Dydejczyk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-12       Impact factor: 9.236

7.  Oral health-related quality of life in patients undergoing chronic hemodialysis.

Authors:  Ewa Rodakowska; Magdalena Wilczyńska-Borawska; Justyna Fryc; Joanna Baginska; Beata Naumnik
Journal:  Patient Prefer Adherence       Date:  2018-06-01       Impact factor: 2.711

Review 8.  Nutritional Status in Peritoneal Dialysis: Nutritional Guidelines, Adequacy and the Management of Malnutrition.

Authors:  Thomas Kiebalo; Jacqueline Holotka; Ireneusz Habura; Krzysztof Pawlaczyk
Journal:  Nutrients       Date:  2020-06-08       Impact factor: 5.717

9.  Resistance to erythropoiesis-stimulating agents is associated with arterial microcalcification in early hemodialysis patients.

Authors:  Hye Sung Won; Su Jin Choi; Yu Seon Yun; Ok-Ran Shin; Yoon Ho Ko; Young Soo Kim; Sun Ae Yoon; Young Ok Kim
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

Review 10.  An update on coronary artery disease and chronic kidney disease.

Authors:  Baris Afsar; Kultigin Turkmen; Adrian Covic; Mehmet Kanbay
Journal:  Int J Nephrol       Date:  2014-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.